Humacyte
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $406 | $495 | $467 | $753 |
Gross Profit | -825 | -1,543 | -10,403 | -1,372 |
EBITDA | -33,144 | -13,558 | -19,923 | -13,033 |
EBIT | -34,481 | -15,348 | -21,711 | -14,898 |
Net Income | -36,802 | -17,619 | -24,804 | -17,510 |
Net Change In Cash | 406 | 495 | 467 | 753 |
Free Cash Flow | -22,165 | -25,279 | -26,162 | -23,953 |
Cash | 79,903 | 48,539 | 50,497 | 19,488 |
Basic Shares | 234,182 | 197,846 | 158,160 | 158,313 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $2,038 | $0 | $0 | $1,565 |
Gross Profit | -15,009 | -7,190 | -76,550 | -6,690 |
EBITDA | -22,238 | -132,234 | -96,458 | 2,445 |
EBIT | -29,583 | -139,424 | -104,177 | -5,765 |
Net Income | -40,833 | -148,701 | -110,776 | -11,965 |
Net Change In Cash | 2,038 | 0 | 0 | 1,565 |
Cost of Revenue | -67,730 | |||
Free Cash Flow | -105,926 | -99,694 | -75,585 | -72,177 |
Cash | 50,497 | 44,937 | 80,448 | 149,772 |
Basic Shares | 158,160 | 118,479 | 103,420 | 103,051 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.16 |
2026-03-31 | -$0.09 |
2025-12-31 | -$0.18 |
2025-09-30 | -$0.11 |